Cover Image
市場調查報告書

MediPoint:親水膠體 - 全球市場的分析與預測

MediPoint: Hydrocolloids - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 606444
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:親水膠體 - 全球市場的分析與預測 MediPoint: Hydrocolloids - Global Analysis and Market Forecasts
出版日期: 2017年12月01日 內容資訊: 英文 110 Pages
簡介

本報告提供全球親水膠體市場相關調查,市場概要,市場成長的影響要素,產品概要,各地區/國家的平均價格、收益額、成長率的變化與預測,市場佔有率,主要企業的簡介,市場未來展望等總括性彙整。

第1章 關於作者

第2章 目錄

第3章 摘要整理

第4章 簡介

  • 成長要素
  • 相關調查
  • 出版預定的調查報告

第5章 市場概要

  • 治療趨勢
  • 收益趨勢
  • 企業佔有率分析

第6章 市場評估

  • 法規上的課題:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
  • 價格趨勢:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第7章 市場機會,未滿足需求,障礙

  • 市場機會
    • 蛆療法
    • 壓迫療法
    • 皮瓣重建
  • 未滿足需求
    • 傷口浸軟、異常增生
    • 抗菌劑的有效性
  • 障礙
    • 償付制度的缺乏
    • 法規上的課題
    • 臨床資料的不足

第8章 市場考察

  • 市場概要
  • 北美
    • 加拿大
    • 墨西哥
    • 美國
  • 歐洲
    • 丹麥,芬蘭,挪威,瑞典
    • 比利時,法國,荷蘭
    • 德國,瑞士
    • 英國,愛爾蘭
    • 義大利,葡萄牙,西班牙
    • 奧地利,捷克,匈牙利,波蘭
    • 希臘,俄羅斯,土耳其
  • 亞太地區
    • 澳洲,紐西蘭
    • 中國,台灣
    • 印度
    • 日本
    • 韓國
  • 南美
    • 巴西
    • 阿根廷,智利
  • 中東、非洲
    • 以色列
    • 南非
    • 埃及,沙烏地阿拉伯,阿拉伯聯合大公國

第9章 競爭評估

  • 市場概要
  • M&A
  • 3M Health care
  • Smith & Nephew
  • ConvaTec
  • Coloplast
  • 其他的企業

第10章 附錄

  • 參考文獻
  • 簡稱一覽
  • 調查手法
  • 關於MediPoint
  • 關於GlobalData
  • 聯絡處
  • 免責聲明
目錄
Product Code: GDME0274MAR

Global robotic surgical systems market for general surgery, excluding accessories, was estimated to be around $0.75B in 2017 across the 39 markets covered in this report. By the end of the forecast period in 2024, it is estimated that the market will grow to approximately $1.8B at a Compound Annual Growth Rate (CAGR) of over 13%.

Key drivers of the robotic surgical systems market for general surgery in the forecast period are -

  • Expected increase in the number of indications and procedures that can be carried out using robotic surgical systems.
  • New companies are expected to enter the robotic surgical systems market with their own products in the forecast period.

North American market accounts for about 72% of the global market for robotic surgical systems. The market in the region is projected to grow at a CAGR of over 12.7% from 2017 to reach a value of $1.3B in 2024.European market accounts for about around 14% of the global market for robotic surgical systems. The market in the region is projected to grow at a CAGR of 18% from 2017 to reach a value of $343M in 2024.

Asia-Pacific (APAC) market accounts for about 13% of the global market for robotic surgical systems. The market in the region is projected to grow at a CAGR of more than 12.5% from 2017 to cross $232M in 2024.South American market accounts for about 1% of the global market for robotic surgical systems. The market in the region is projected to grow at a CAGR of around 13.6% from 2017 to reach a value of about $11M in 2024.

Middle East and Africa market accounts for about 1% of the global market for robotic surgical systems. The market in the region is projected to grow at a CAGR of 10.3% from 2017 to reach a value of $8.9M in 2024.

Even though the first robotic surgical systems were approved for use in the healthcare setting in 2000, the products are still considered to be an innovation in hospitals where they are used. The systems are intended to assist the surgeons carry out surgical procedures; benefits to surgeons include a surgical procedure that can be carried out with less tremor compared to a conventional surgical technique, ease of access to anatomies that are difficult to reach, and, in some cases, lower post-operative complications in patients.

Leading player in the global robotic surgical systems market is Intuitive Surgical. However, other companies are expected to enter this market with their own products in the forecast period.

The report "MediPoint: Hydrocolloids - Global Analysis and Market Forecasts", focuses on the market outlook for robotic surgical systems within general surgery in the global market. It analyzes and discusses the major drivers and barriers of adopting these systems, and provides an in-depth understanding of the future outlook for this market by geography, with an overall emphasis on the current and future trends in the 39 countries analyzed.

Companies mentioned in this report: 3M Health care, Smith & Nephew Plc (Smith & Nephew), ConvaTec Group Plc (ConvaTec), Coloplast A/S (Coloplast).

Scope

  • Competitive assessment: Currently marketed Hydrocolloids and evolving competitive landscape
  • In-depth analysis of unmet needs and adoption trends of different Hydrocolloids
  • Insightful review of the key industry drivers, opportunities, restraints and challenges.
  • Annualized total Hydrocolloids market revenue by segment and market outlooks from 2017-2024.
  • Other key topics covered include strategic competitive assessment, identification of unmet needs, and market dynamics.

Reasons to buy

The report will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Hydrocolloids market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hydrocolloids market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Hydrocolloids market from 2017-2024.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

1 About the Authors 2

2 Table of Contents 3

  • 2.1 List of Tables 6
  • 2.2 List of Figures 6

3 Executive Summary 7

  • 3.1 Overview 7
  • 3.2 Market Dynamics 14
  • 3.3 Key Players in the Market 14
  • 3.4 Market Future Outlook 14

4 Introduction 16

  • 4.1 Catalyst 16
  • 4.2 Related Reports 16
  • 4.3 Upcoming Related Reports 16

5 Market Outlook 17

  • 5.1 Procedure Trends 17
  • 5.2 Revenue Trends 24
  • 5.3 Company Share Analysis 30

6 Market Access 33

  • 6.1 Regulatory Issues 33
    • 6.1.1 North America 33
    • 6.1.2 Europe 37
    • 6.1.3 APAC 57
    • 6.1.4 South America 64
    • 6.1.5 Middle East and Africa 67
  • 6.2 Pricing Trends 74
    • 6.2.1 North America 74
    • 6.2.2 Europe 75
    • 6.2.3 APAC 77
    • 6.2.4 South America 78
    • 6.2.5 Middle East and Africa 78

7 Opportunities, Unmet Needs and Barriers 79

  • 7.1 Opportunities 79
    • 7.1.1 Maggot Therapy 79
    • 7.1.2 Use with compression therapy 79
    • 7.1.3 Flap construction with hydrocolloid dressing template 80
  • 7.2 Unmet Needs 80
    • 7.2.1 Wound maceration and hypergranulation 80
    • 7.2.2 Clearer gels for wound assessment 80
    • 7.2.3 Efficacy of antimicrobials 80
  • 7.3 Barriers 81
    • 7.3.1 Lack of reimbursement 81
    • 7.3.2 Regulatory issues 81
    • 7.3.3 Lack of clinical data 82

8 Market Insights 83

  • 8.1 Overview 83
  • 8.2 North America 83
    • 8.2.1 Canada 83
    • 8.2.2 Mexico 83
    • 8.2.3 US 83
  • 8.3 Europe 84
    • 8.3.1 Denmark, Finland, Norway, and Sweden 84
    • 8.3.2 Belgium, France, and Netherlands 85
    • 8.3.3 Germany and Switzerland 85
    • 8.3.4 UK and Ireland 85
    • 8.3.5 Italy, Portugal, and Spain 86
    • 8.3.6 Austria, Czech Republic, Hungary, and Poland 86
    • 8.3.7 Greece, Russia, and Turkey 86
  • 8.4 APAC 87
    • 8.4.1 Australia and New Zealand 87
    • 8.4.2 China and Taiwan 87
    • 8.4.3 India 87
    • 8.4.4 Japan 88
    • 8.4.5 South Korea 88
  • 8.5 South America 88
    • 8.5.1 Brazil 88
    • 8.5.2 Argentina and Chile 89
  • 8.6 Middle East and Africa 89
    • 8.6.1 Israel 89
    • 8.6.2 South Africa 89
    • 8.6.3 Egypt, Saudi Arabia, and United Arab Emirates 89

9 Competitive Assessment 90

  • 9.1 Overview 90
  • 9.2 Mergers and Acquisitions 90
  • 9.3 3M Health care 90
    • 9.3.1 Overview 90
    • 9.3.2 Portfolio Assessment 91
    • 9.3.3 Competitive Positioning 91
  • 9.4 Smith & Nephew 92
    • 9.4.1 Overview 92
    • 9.4.2 Portfolio Assessment 92
    • 9.4.3 Competitive Positioning 92
  • 9.5 ConvaTec 93
    • 9.5.1 Overview 93
    • 9.5.2 Portfolio Assessment 93
    • 9.5.3 Competitive Positioning 94
  • 9.6 Coloplast 94
    • 9.6.1 Overview 94
    • 9.6.2 Portfolio Assessment 95
    • 9.6.3 Competitive Positioning 95
  • 9.7 Other Players 96

10 Appendix 97

  • 10.1 Bibliography 97
  • 10.2 Abbreviations 97
  • 10.3 Methodology 105
    • 10.3.1 Coverage 105
    • 10.3.2 Secondary Research 105
    • 10.3.3 Forecasting Methodology 106
    • 10.3.4 Primary Research Summary 107
  • 10.4 About MediPoint 108
  • 10.5 About GlobalData 108
  • 10.6 Contact Us 108
  • 10.7 Disclaimer 109

List of Tables

  • Table 1: Key Metrics in the Global hydrocolloid Market 7
  • Table 2: North America Hydrocolloid Dressings Volume Forecast, 2015 -2024 ("in thousands") 17
  • Table 3: Europe Hydrocolloid Dressings Volume Forecast, 2015 - 2024 ("in thousands") 18
  • Table 4: APAC Hydrocolloid Dressings Volume Forecast, 2015 - 2024 ("in thousands") 21
  • Table 5: South America Hydrocolloid Dressings Volume Forecast, 2015 - 2024 ("in thousands") 22
  • Table 6: Middle East and Africa Hydrocolloid Dressings Volume Forecast, 2015 - 2024 ("in thousands") 23
  • Table 7: North America Hydrocolloid Dressings Market Revenue Forecast ($M), 2015 -2024 24
  • Table 8: Europe Hydrocolloid Dressings Revenue Forecast ($M), 2015 -2024 25
  • Table 9: APAC Hydrocolloid Dressings Market Revenue Forecast ($M), 2015 -2024 28
  • Table 10: South America Hydrocolloid Dressings Market Revenue Forecast ($M), 2015-2024 29
  • Table 11: Middle East and Africa Hydrocolloid Dressings Market Revenue Forecast ($M), 2015-2024 30
  • Table 12: North America Hydrocolloid Dressings Company Share Analysis, 2017 30
  • Table 13: Europe Hydrocolloid Dressings Company Share Analysis, 2017 31
  • Table 14: APAC Hydrocolloid Dressings Company Share Analysis, 2017 32
  • Table 15: South America Hydrocolloid Dressings Company Share Analysis, 2017 32
  • Table 16: Middle East and Africa Hydrocolloid Dressings Company Share Analysis, 2017 32
  • Table 17: North America Hydrocolloid Dressings Average Selling Price Forecast ($), 2015 -2024 74
  • Table 18: Europe Hydrocolloid Dressings Average Selling Price Forecast ($), 2015 -2024 75
  • Table 19: APAC Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 77
  • Table 20: South America Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 78
  • Table 21: Middle East and Africa Hydrocolloid Dressings Average Selling Price Forecast ($), 2015-2024 78
  • Table 22: Mergers and Acquisitions, 2017 90
  • Table 23: 3M Healthcare - Key Marketed Products Assessment 91
  • Table 24: Summary of Other Players in the 3M Healthcare in the Hydrocolloid Dressings Market, 2017 91
  • Table 25: Smith & Nephew - Key Marketed Products Assessment 92
  • Table 26: SWOT Analysis of Smith & Nephew in the Hydrocolloid Dressings Market, 2017 93
  • Table 27: ConvaTec - Key Marketed Products Assessment 93
  • Table 28: SWOT Analysis of ConvaTec in the Hydrocolloid dressings Market, 2017 94
  • Table 29: Coloplast - Key Marketed Products Assessment 95
  • Table 30: SWOT Analysis of Coloplast in the Hydrocolloid dressings Market, 2017 95
  • Table 31: Summary of Other Players in the Hydrocolloid Dressings Market, 2017 96
Back to Top